Suppr超能文献

南非人群中的亨廷顿病发生在不同的、具有种族差异的遗传单倍型上。

Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.

机构信息

1] Division of Human Genetics, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa [2] Centre for Molecular Medicine and Therapeutics, Child and Family Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.

出版信息

Eur J Hum Genet. 2013 Oct;21(10):1120-7. doi: 10.1038/ejhg.2013.2. Epub 2013 Mar 6.

Abstract

Huntington disease (HD) is a neurodegenerative disorder resulting from the expansion of a CAG trinucleotide repeat in the huntingtin (HTT) gene. Worldwide prevalence varies geographically with the highest figures reported in populations of European ancestry. HD in South Africa has been reported in Caucasian, black and mixed subpopulations, with similar estimated prevalence in the Caucasian and mixed groups and a lower estimate in the black subpopulation. Recent studies have associated specific HTT haplotypes with HD in distinct populations. Expanded HD alleles in Europe occur predominantly on haplogroup A (specifically high-risk variants A1/A2), whereas in East Asian populations, HD alleles are associated with haplogroup C. Whether specific HTT haplotypes associate with HD in black Africans and how these compare with haplotypes found in European and East Asian populations remains unknown. The current study genotyped the HTT region in unaffected individuals and HD patients from each of the South African subpopulations, and haplotypes were constructed. CAG repeat sizes were determined and phased to haplotype. Results indicate that HD alleles from Caucasian and mixed patients are predominantly associated with haplogroup A, signifying a similar European origin for HD. However, in black patients, HD occurs predominantly on haplogroup B, suggesting several distinct origins of the mutation in South Africa. The absence of high-risk variants (A1/A2) in the black subpopulation may also explain the reported low prevalence of HD. Identification of haplotypes associated with HD-expanded alleles is particularly relevant to the development of population-specific therapeutic targets for selective suppression of the expanded HTT transcript.

摘要

亨廷顿病 (HD) 是一种神经退行性疾病,由亨廷顿 (HTT) 基因中的 CAG 三核苷酸重复扩展引起。全球患病率因地理位置而异,欧洲血统人群的报告发病率最高。南非的 HD 已在白种人、黑人和混合人群中报告,白种人和混合人群的估计患病率相似,黑人群体的估计患病率较低。最近的研究将特定的 HTT 单倍型与不同人群中的 HD 相关联。欧洲扩张的 HD 等位基因主要发生在单倍群 A 上(特别是高危变体 A1/A2),而在东亚人群中,HD 等位基因与单倍群 C 相关联。特定的 HTT 单倍型是否与南非黑人中的 HD 相关联,以及这些单倍型与欧洲和东亚人群中的单倍型相比如何,目前尚不清楚。本研究对每个南非人群中的未受影响个体和 HD 患者进行了 HTT 区域的基因分型,并构建了单倍型。确定了 CAG 重复大小并进行了单倍型相位测定。结果表明,来自白人和混合患者的 HD 等位基因主要与单倍群 A 相关,表明 HD 具有类似的欧洲起源。然而,在黑人患者中,HD 主要发生在单倍群 B 上,这表明该突变在南非有几个不同的起源。黑人亚群中缺乏高危变体 (A1/A2) 也可能解释了报告的 HD 低患病率。确定与 HD 扩展等位基因相关的单倍型对于开发针对选择性抑制扩展 HTT 转录本的特定人群治疗靶点尤其重要。

相似文献

1
Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.
Eur J Hum Genet. 2013 Oct;21(10):1120-7. doi: 10.1038/ejhg.2013.2. Epub 2013 Mar 6.
2
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Eur J Hum Genet. 2011 May;19(5):561-6. doi: 10.1038/ejhg.2010.229. Epub 2011 Jan 19.
3
The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
Eur J Hum Genet. 2017 Feb;25(3):332-340. doi: 10.1038/ejhg.2016.169. Epub 2016 Dec 21.
4
The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
Am J Med Genet B Neuropsychiatr Genet. 2018 Apr;177(3):346-357. doi: 10.1002/ajmg.b.32618. Epub 2018 Feb 20.
5
A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
Am J Hum Genet. 2019 Dec 5;105(6):1112-1125. doi: 10.1016/j.ajhg.2019.10.011. Epub 2019 Nov 7.
8
CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.
Am J Hum Genet. 2009 Mar;84(3):351-66. doi: 10.1016/j.ajhg.2009.02.003. Epub 2009 Feb 26.
9
Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East.
Genet Med. 2020 Nov;22(11):1903-1908. doi: 10.1038/s41436-020-0895-1. Epub 2020 Jul 14.
10
Haplotype analysis encompassing HTT gene in Chinese patients with Huntington's disease.
Eur J Neurol. 2020 Feb;27(2):273-279. doi: 10.1111/ene.14072. Epub 2019 Oct 17.

引用本文的文献

1
Risk Factors and Interventions for Suicide in Huntington's Disease-A Systematic Review.
J Clin Med. 2024 Jun 12;13(12):3437. doi: 10.3390/jcm13123437.
2
Atypical Presentations of Huntington Disease-like 2 in South African Individuals.
Mov Disord Clin Pract. 2024 Jul;11(7):850-854. doi: 10.1002/mdc3.14052. Epub 2024 May 9.
4
Huntington disease-like 2: insight into neurodegeneration from an African disease.
Nat Rev Neurol. 2024 Jan;20(1):36-49. doi: 10.1038/s41582-023-00906-y. Epub 2023 Dec 19.
5
A deep population reference panel of tandem repeat variation.
Nat Commun. 2023 Oct 23;14(1):6711. doi: 10.1038/s41467-023-42278-3.
6
A clinical study and future prospects for bioactive compounds and semi-synthetic molecules in the therapies for Huntington's disease.
Mol Neurobiol. 2024 Mar;61(3):1237-1270. doi: 10.1007/s12035-023-03604-4. Epub 2023 Sep 12.
7
A deep population reference panel of tandem repeat variation.
bioRxiv. 2023 Mar 12:2023.03.09.531600. doi: 10.1101/2023.03.09.531600.
8
What the Gut Tells the Brain-Is There a Link between Microbiota and Huntington's Disease?
Int J Mol Sci. 2023 Feb 24;24(5):4477. doi: 10.3390/ijms24054477.
10
Prevalence and Incidence of Huntington's Disease: An Updated Systematic Review and Meta-Analysis.
Mov Disord. 2022 Dec;37(12):2327-2335. doi: 10.1002/mds.29228. Epub 2022 Sep 26.

本文引用的文献

2
The utilization and outcome of diagnostic, predictive, and prenatal genetic testing for huntington disease in johannesburg, South Africa.
Genet Test Mol Biomarkers. 2012 Jan;16(1):58-62. doi: 10.1089/gtmb.2011.0007. Epub 2011 Aug 12.
3
HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
Eur J Hum Genet. 2011 May;19(5):561-6. doi: 10.1038/ejhg.2010.229. Epub 2011 Jan 19.
4
The clinical and genetic features of Huntington disease.
J Geriatr Psychiatry Neurol. 2010 Dec;23(4):243-59. doi: 10.1177/0891988710383573. Epub 2010 Oct 5.
5
Haplotype background, repeat length evolution, and Huntington's disease.
Am J Hum Genet. 2009 Dec;85(6):939-42. doi: 10.1016/j.ajhg.2009.11.002.
6
Huntington's disease: the case for genetic modifiers.
Genome Med. 2009 Aug 21;1(8):80. doi: 10.1186/gm80.
7
Unstable familial transmissions of Huntington disease alleles with 27-35 CAG repeats (intermediate alleles).
Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):314-20. doi: 10.1002/ajmg.b.30970.
8
Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients.
Curr Biol. 2009 May 12;19(9):774-8. doi: 10.1016/j.cub.2009.03.030. Epub 2009 Apr 9.
9
A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference.
Exp Neurol. 2009 Jun;217(2):312-9. doi: 10.1016/j.expneurol.2009.03.004. Epub 2009 Mar 13.
10
CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.
Am J Hum Genet. 2009 Mar;84(3):351-66. doi: 10.1016/j.ajhg.2009.02.003. Epub 2009 Feb 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验